MedDiag is a start-up company incorporated in April 2015 to exploit the research work of two academics who have developed an innovative method for diagnosing early-stage cancer of the bladder, the fourth most common cancer among men in France. The company’s experience with open innovation is typical of high-tech, research-based start-ups which depend on external collaborations to complete their product development.
(This is a pseudonym since the company prefers anonimity)